創益生技股份有限公司

Banner Up

Milestones

    2011
  • 04

    CYBiotech, previously known as the consumer medical care branch of TTY Biopharm Company, ltd., was established in April 28th, 2011.

  • 10

    Official name and organizational changed to "CYBiotech".

    2012
  • 02

    Product: "敏自寧 L. j EM" health foods approval was certified by the Taiwan Ministry of Health and Welfare

  • 03

    Immortal Fame Global Ltd., a 100% CYBiotech subsidiary, was established in Samoa.

  • 09

    CYBiotech was awarded the 10th Annual Top 10 Enterprise Gold Torch Award by the Outstanding Enterprise Manager Association.

  • 11

    Chuang Yi (Shanghai)Trading limited, a 100% CYBiotech subsidiary, was established in Shanghai, China.

    2013
  • 03

    Product: "天天佳 L. paracasei" health foods approval was certified by the Taiwan Ministry of Health and Welfare.

  • 07

    Capital Increased by cash in July 29th, 2013, to NTD$170,720,000.

  • 07

    Arena has authorized CYBiotech to develop, register, promote, distribute, market, and sell 沛麗婷膜衣錠10毫克 BELVIQ® F.C. Tablets 10mg weight management products in Taiwan. Arenahas authorized CYBiotech as the exclusive Taiwan regional licensed distributor.

    2014
  • 02

    The 沛麗婷膜衣錠10毫克 BELVIQ® F.C. Tablets 10mg clinical assessment project established by the National Taiwan University Hospital, China Medical University Hospital, and National Cheng Kung University Hospital was sent for approval by the Ethics Committee, Ministry of Health and Welfare, for assessing patient safety and drug effectiveness.

  • 08

    Awarded as Professionals Approved Company by the Taiwan Industrial Development Bureau, Ministry of Economic Affairs

  • 11

    The BELVIQ® clinical assessment project established by the National Taiwan University Hospital, China Medical University Hospital, and National Cheng Kung University Hospital was approved by the Ethics Committee, Ministry of Health and Welfare.

    2015
  • 03

    The EMANGAIN Probiotics was awarded the innovative health care food award by the Health Food Society of Taiwan.

  • 04

    Product: "舒敏佳 L. r MP108" health foods approval was certified by the Taiwan Ministry of Health and Welfare.

  • 05

    Capital Increased by cash in May 21st, 2015, to NTD$ 204,720,000.

  • 06

    Product: "活源蔘膠囊" health supplement food approval was certified by the Taiwan Ministry of Health and Welfare.

  • 10

    The 沛麗婷膜衣錠10毫克 BELVIQ® F.C. Tablets 10mg weight management drug was submitted to the Taiwan Food and Drug Administration for approval.

  • 12

    CYBiotech’s stock retroactive public issuance was approved by Financial Supervisory Commission, R.O.C.(Taiwan) Securities and Futures Bureau, in January 20th, 2016.

    2016
  • 01

    CYBiotech’s stock was listed as an emerging stock the Taipei Exchange(GreTai Securities Market) in January 20th, 2016.

  • 10

    Capital Increased by cash in October 14th, 2016, to NTD$ 229,720,000.

    2017
  • 07

    Product: "沛麗婷膜衣錠10毫克 BELVIQ® F.C. Tablets 10mg" drug permit license approval was certified by the Taiwan Ministry of Health and Welfare.

    2019
  • 12

    Capital Increased by cash in October 16th, 2019, to NTD$ 269,720,000.

    2021
  • 01

    Capital Increased by cash in October 12th, 2021, to NTD$ 339,356,370.